Abstract:Background: Curcumin (CUR) has been linked with antioxidant, anti-inflammatory, antimicrobial, anti amyloid, and antitumor effects, but its application is limited because of its low aqueous solubility and poor oral bioavailability. Methods: To improve its bioavailability and water solubility, we synthesized two series of poly (epsilon-Caprolactone)-poly (ethylene glycol)-poly (epsilon-Caprolactone) triblock copolymers by ring-opening polymerization of poly (ethylene glycol) and epsilon-Caprolactone, with stannous 2-ethylhexanoate as the catalyst. Structure of the copolymers was characterized by proton nuclear magnetic resonance spectroscopy, Fourier transform infrared spectroscopy, and gel permeation chromatography. The nanoparticles (NPs) were prepared using a probe-type ultrasonic emulsion and solvent evaporation method. To obtain an optimal delivery system, we explored the effect of the length of the copolymers' hydrophilic and hydrophobic chains on the encapsulation of hydrophobic CUR, performing entrapment efficiency and drug loading evaluations, as well as studying the particle distribution and in vitro release using the direct dispersion method. Finally, study of the in vivo pharmacokinetics of the CUR-loaded NPs was also carried out on selected copolymers in comparison with CUR solution formulations. Results: CUR was encapsulated with 94.3% and 95.5% efficiency in biodegradable nanoparticulate formulations based on NP43 and NP63, respectively. Dynamic laser light scattering and transmission electron microscopy indicated a particle diameter of 55.6 nm and 62.4 nm for NP43 and NP63, respectively. Fourier transform infrared spectroscopy and differential scanning calorimetry analysis of the NPs showed that CUR was encapsulated into the NPs. The in vitro release experiments showed that NP63 controlled the release of CUR more effectively, with only 55% of CUR released after 96 hours. In comparison with the free-drug solution in vivo, encapsulation of the CUR in NP63 increased mean residence time from 0.169 to 40.148 hours and the area under the concentration-time curve 4.178-fold. Conclusion: CUR was effectively entrapped by the prepared NPs, which could improve the solubility of CUR and prolong its retention in the systemic circulation.

Curcumin-Loaded Lipid Cubic Liquid Crystalline Nanoparticles: Preparation, Optimization, Physicochemical Properties and Oral Absorption

Preparation and Physiochemical Properties of Curcumin-loaded Lipid Cubic Liquid Crystalline Nanoparticles

Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation

Preparation and pharmacokinetics of curcumin nanostructured lipid carriers in rats

N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations

Physicochemical and In Vitro Digestion Properties of Curcumin-Loaded Solid Lipid Nanoparticles with Different Solid Lipids and Emulsifiers

Elaboration and Characterization of Curcumin-Loaded Tri-CL-mPEG Three-Arm Copolymeric Nanoparticles by a Microchannel Technology

Curcumin Loaded Nanoliposomes Localization by Nanoscale Characterization

Studying the Characteristics of Curcumin-Loaded Liposomal Nanoparticles

Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.

Preparation and characterization of curcumin-loaded methoxy poly(ethylene glycol)-block-poly(γ-cholesterol-l-glutamate) nanoparticles

Polymeric Nanoparticles for Increasing Oral Bioavailability of Curcumin

Inducing Sustained Release and Improving Oral Bioavailability of Curcumin Via Chitosan Derivatives-Coated Liposomes.

Curcumin-loaded Mixed Micelles: Preparation, Optimization, Physicochemical Properties and Cytotoxicity in Vitro

Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers.

Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.

Development of a Curcumin-Loaded Lecithin/Chitosan Nanoparticle Utilizing a Box-Behnken Design of Experiment: Formulation Design and Influence of Process Parameters

PLGA Nanoparticles Improve the Oral Bioavailability of Curcumin in Rats: Characterizations and Mechanisms.

Preparation, Characterization, in Vitro Release, and Pharmacokinetic Studies of Curcumin-Loaded Mpeg–pvl Nanoparticles

N-trimethyl Chitosan Chloride-Coated Liposomes for the Oral Delivery of Curcumin.

Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release in vitro and pharmacokinetics in vivo